Rejection and recipient age

Transplant Immunology

Volumn 10, Issue 2-3, 2002, Pages 125-132

  Bradley, Benjamin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ageing; Corneal transplantation; Immunosuppression; Rejection; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; PERFORIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AGE; AGING; ASSAY; CELL ACTIVATION; CELL KILLING; CELLULAR IMMUNITY; CORNEA TRANSPLANTATION; CYTOKINE RELEASE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; ELDERLY CARE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INVOLUTION; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MITOSIS INHIBITION; MORTALITY; ORGAN DONOR; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS FUNCTION;

ACUTE DISEASE; AGING; ANIMALS; CADAVER; CORNEAL TRANSPLANTATION; CYTOKINES; DRUG RESISTANCE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MEMBRANE GLYCOPROTEINS; METABOLIC DETOXICATION, DRUG; MICE; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 0036345218     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00058-8     Document Type: Review

References (124)

1. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28 -/- mice
2. Morphologic and functional development of whole human fetal stomachs grafted into nude mice
3. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice
4. Role of CD4[+] and CD8[+] T-cells in allorecognition: Lessons from corneal transplantation
5. Interleukin-18 production following murine cardiac transplantation: Correlation with histologic rejection and the induction of INF-gamma
6. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes
7. Heterogeneity of T-cell clones specific for a single indirect alloantigenic epitope [I-Ab/H-2Kd54-68] that mediate transplant rejection
8. The role of cytotoxic T lymphocytes in corneal allograft rejection
9. Role of CD4+ T-cells in immunobiology of orthotopic corneal transplants in mice
10. The intragraft CD8+ T-cell response in renal allograft rejection in the mouse
11. CD4+ but not CD8+ cells are essential for allorejection
12. Differences in the contribution of CD4+ T-cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression
13. Cytotoxic effector molecule gene expression in acute renal allograft rejection: Correlation with clinical outcome; Histopathology and function of the allograft
14. Course of renal allograft histopathology after transplantation in early childhood
15. Immunologic monitoring in lung allograft recipients
16. Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients
17. Pathology of human intestinal transplantation
18. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T-cells
19. Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Molecular, immunocytochemical, and histopathologic investigations
20. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation
21. Clinical significance of allograft glomerulopathy
22. The impact of recurrent glomerulonephritis on graft survival in recipients of human histocompatibility leucocyte antigen-identical living related donor grafts
23. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics
24. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection
25. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
26. Chronic allograft nephropathy: An update
27. Molecular analyses of human renal allografts: Differential intragraft gene expression during rejection
28. Intragraft expression of transforming growth factor-beta 1 by a novel quantitative reverse transcription polymerase chain reaction ELISA in long-lasting kidney recipients
29. Effect of histological damage on long-term kidney transplant outcome
30. The Banff schema four years later
31. Prognostic value of the Banff classification
32. Banff schema for grading liver allograft rejection: An international consensus document
33. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel
34. Living donor transplants
35. Spousal and other living renal donor transplants
36. The UNOS Scientific Renal Transplant Registry - Ten years of kidney transplants
37. Effects of explosive brain death on cytokine activation of peripheral organs in the rat
38. Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation
39. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function
40. Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection
41. The immune privilege of corneal allografts
42. CD95 ligand [FasL]-induced apoptosis is necessary for corneal allograft survival
43. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants
44. Conclusions of the corneal transplant follow-up study. Collaborating Surgeons
45. The immunology of corneal graft rejection
46. Rejected human corneal grafts. I. Clinical study
47. Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection
48. Local therapy of corneal allograft rejection with cyclosporine
49. Age-associated decline in cardiac allograft rejection
50. Age and liver transplantation: A report of the Liver Transplantation Database
51. Lung transplantation in patients over the age of 50
52. Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age
53. Renal transplantation in older adults: Is graft survival affected by age? A case control study
54. The vanishing importance of age in renal transplantation
55. Acute rejection: The impact of recipient age
56. Does the risk of acute rejection really decrease with increasing recipient age?
57. Elderly transplant recipients may require less immunosuppression
58. Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols
59. Increased immunosuppressive vulnerability in elderly renal transplant recipients
60. Loss of cyclosporin-resistant allospecific T-cells with age
61. Recipient age as an independent risk factor for chronic renal allograft failure
62. The serial cultivation of human diploid strains
63. Replicative senescence of T-cells: Does the Hayflick limit lead to immune exhaustion?
64. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
65. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age
66. Telomere diminution as a cause of immune failure in old age: An unfashionable demurral
67. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns
68. Thymic involution with ageing: Obsolescence or good housekeeping?
69. Thymic involution: Effect on T-cell differentiation
70. Changes in the human thymus during aging
71. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T-cell development
72. Thymic aging and T-cell regeneration
73. The T-cell in the ageing individual
74. Both age and gender affect thymic output: More recent thymic migrants in females than males as they age
75. Quantification of thymic function by measuring T-cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys
76. Identification of a human recent thymic emigrant phenotype
77. V beta gene repertoires in aging mice
78. V beta gene repertoire in the aging mouse: A developmental perspective
79. Decline, with age, in the proportion of mouse T-cells that express IL-2 receptors after mitogen stimulation
80. The aging immune system: Primer and prospectus
81. Shortage of circulating naive CD8[+] T-cells provides new insights on immunodeficiency in aging
82. Postthymic development of CD28-CD8+ T-cell subset: Age-associated expansion and shift from memory to naive phenotype
83. Expansion of cytotoxic CD8+CD28- T-cells in healthy ageing people, including centenarians
84. Oligoclonality of CD8+ T-cells in health and disease: Aging, infection, or immune regulation?
85. Loss of CD28 expression on T lymphocytes: A marker of replicative senescence
86. Shortened telomeres in clonally expanded CD28-CD8+ T-cells imply a replicative history that is distinct from their CD28+CD8+ counterparts
87. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space
88. Production of cytokines by lymphocytes from spleen, mesenteric lymph node and intestinal lamina propria of pigs
89. Conditions affecting enhanced corneal allograft survival by oral immunization
90. Fetal microchimerisms in the mother: Immunologic implications
91. Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood
92. Tolerance to maternal immunoglobulins: Resilience of the specific T-cell repertoire in spite of long-lasting perturbations
93. Epitope spreading
94. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: Evidence from trans-vivo DTH and alloantibody analysis
95. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice
96. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12
97. Age-associated changes in interferon-gamma and interleukin-4 secretion by purified human CD4+ and CD8+ T-cells
98. Influence of age and HLA type on interferon-gamma [IFN-gamma] responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 [LSA-1]
99. Ageing is associated with a prolonged fever response in human endotoxemia
100. Lymphokine-activated killer cells derived from murine bone marrow: Age-associated difference in precursor cell populations demonstrated by response to interferon
101. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: Reversal by the combination of gamma interferon and growth hormone
102. IL-12 directly stimulates expression of IL-10 by CD5+ B-cells and IL-6 by both CD5+ and CD5- B-cells: Possible involvement in age-associated cytokine dysregulation
103. NK and NK/T cells in human senescence
104. Age-related decrement in cytotoxic T lymphocyte [CTL] activity is associated with decreased levels of mRNA encoded by two CTL-associated serine esterase genes and the perforin gene in mice
105. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells
106. Perforins in human cytolytic cells: The effect of age
107. Clinical application of molecular biology: A study of allograft rejection with polymerase chain reaction
108. Increased production of TGF-beta and IL-6 by aged spleen cells
109. Plasma-transforming growth factor beta[1] and platelet activation: Implications for studies in transplant recipients
110. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: Increased expression of p21[WAF1/Cip1] as a disease marker and the influence of immunosuppressive drugs
111. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection
112. Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies
113. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
114. Increased Zap-70 association with CD3zeta in CD4 T-cells from old mice
115. Effect of aging on T lymphocyte activation
116. Early activation defects in T lymphocytes from aged mice
117. Decreased proteosome-mediated degradation in T-cells from the elderly: A role in immune senescence
118. Age-related decline in activation of calcium/calmodulin-dependent phosphatase calcineurin and kinase CaMK-IV in rat T-cells
119. Age-related decreases in IL-2 production by human T-cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT
120. The age-related changes in DNA binding activity of AP-1, NK-kappa B, and OCT-1 transcription factors in lymphocytes from rats
121. Cyclosporin pharmacokinetics in the elderly
122. Age-dependent cyclosporine: Pharmacokinetics in marrow transplant recipients
123. Age-matching in renal transplantation
124. Renal transplantation in recipients over the age of 60: The impact of donor age